Body composition indices and tissue loss in patients with resectable gastric adenocarcinoma

Eirik Kjus Aahlin, Tomoyuki Irino, Neil Johns, Torkel Brismar, Magnus Nilsson, Arthur Revhaug, Kristoffer Lassen

Abstract


Background:

Body composition analyses from computed tomography (CT) scans have been used to assess cachexia in cancer patients. We investigated body composition indices, tissue change and treatment outcome in patients with resectable gastric adenocarcinoma.

Methods:

A cohort analysis of all patients treated with curative intent for gastric adenocarcinoma in two Scandinavian university hospitals from 2008-2011 was performed (n=137). Body composition analyses were performed on CT images taken for routine diagnostics and staging. Both preoperative single scans and repeat CT examinations were analyzed.

Results:

Perioperative chemotherapy was given to 58 (42.3%) patients. Forty patients (29.2%) suffered severe postoperative complications and 70 (51.1%) patients died within three years. There was a significant reduction in patients’ lean tissue during neoadjuvant chemotherapy (p=0.001). Poorer survival was observed in patients with preoperative skeletal muscle tissue index within the lowermost quartile, independent of tumor characteristics and neoadjuvant treatment (HR=1.91, 95% CI 1.11-3.28, p=0.019).

Conclusions:

Patients lost lean tissue during neoadjuvant treatment for gastric adenocarcinoma. Low preoperative skeletal muscle index was associated with poorer survival.


Full Text:

PDF

References


Awad, S., Tan, B. H., Cui, H., Bhalla, A., Fearon, K. C., Parsons, S. L., Catton, J. A., and Lobo, D. N. Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer. Clin. Nutr. 31:74-77, 2012.

Tan, B. H., Brammer, K., Randhawa, N., Welch, N. T., Parsons, S. L., James, E. J., and Catton, J. A. Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer. Eur. J. Surg. Oncol. 41:333-338, 2015.

Bringeland, E. A., Wasmuth, H. H., Johnsen, G., Johnsen, T. B., Juel, I. S., Mjones, P., Uggen, P. E., Ystgaard, B., and Gronbech, J. E. Outcomes among patients treated for gastric adenocarcinoma during the last decade. J. Surg. Oncol. 107:752-757, 2013.

Cunningham, D., Allum, W. H., Stenning, S. P., Thompson, J. N., Van de Velde, C. J., Nicolson, M., Scarffe, J. H., Lofts, F. J., Falk, S. J., Iveson, T. J., Smith, D. B., Langley, R. E., Verma, M., Weeden, S., Chua, Y. J., and MAGIC, T. P. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N. Engl. J. Med. 355:11-20, 2006.

Bringeland, E. A., Wasmuth, H. H., Fougner, R., Mjones, P., and Gronbech, J. E. Impact of perioperative chemotherapy on oncological outcomes after gastric cancer surgery. Br. J. Surg. 101:1712-1720, 2014.

Mourtzakis, M., Prado, C. M., Lieffers, J. R., Reiman, T., McCargar, L. J., and Baracos, V. E. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl. Physiol Nutr. Metab. 33:997-1006, 2008.

Prado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., and Baracos, V. E. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 9:629-635, 2008.

Levolger, S., van Vugt, J. L., de Bruin, R. W., and Ijzermans, J. N. Systematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignancies. Br. J. Surg. 102:1448-1458, 2015.

Aahlin, E. K., Trano, G., Johns, N., Horn, A., Soreide, J. A., Fearon, K. C., Revhaug, A., and Lassen, K. Risk factors, complications and survival after upper abdominal surgery: a prospective cohort study. BMC. Surg. 15:83. doi: 10.1186/s12893-015-0069-2.:83-0069, 2015.

Malietzis, G., Aziz, O., Bagnall, N. M., Johns, N., Fearon, K. C., and Jenkins, J. T. The role of body composition evaluation by computerized tomography in determining colorectal cancer treatment outcomes: A systematic review. Eur. J. Surg. Oncol. 41:186-196, 2015.

Lodewick, T. M., van Nijnatten, T. J., van Dam, R. M., van, M. K., Dello, S. A., Neumann, U. P., Olde Damink, S. W., and Dejong, C. H. Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases? HPB (Oxford). 17:438-446, 2015.

Tegels, J. J., van Vugt, J. L., Reisinger, K. W., Hulsewe, K. W., Hoofwijk, A. G., Derikx, J. P., and Stoot, J. H. Sarcopenia is highly prevalent in patients undergoing surgery for gastric cancer but not associated with worse outcomes. J. Surg. Oncol. 112:403-407, 2015.

Prado, C. M., Baracos, V. E., McCargar, L. J., Reiman, T., Mourtzakis, M., Tonkin, K., Mackey, J. R., Koski, S., Pituskin, E., and Sawyer, M. B. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin. Cancer Res. 15:2920-2926, 2009.

Reisinger, K. W., van Vugt, J. L., Tegels, J. J., Snijders, C., Hulsewe, K. W., Hoofwijk, A. G., Stoot, J. H., von Meyenfeldt, M. F., Beets, G. L., Derikx, J. P., and Poeze, M. Functional Compromise Reflected by Sarcopenia, Frailty, and Nutritional Depletion Predicts Adverse Postoperative Outcome After Colorectal Cancer Surgery. Ann. Surg. 261:345-352, 2015.

Cooper, A. B., Slack, R., Fogelman, D., Holmes, H. M., Petzel, M., Parker, N., Balachandran, A., Garg, N., Ngo-Huang, A., Varadhachary, G., Evans, D. B., Lee, J. E., Aloia, T., Conrad, C., Vauthey, J. N., Fleming, J. B., and Katz, M. H. Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer. Ann. Surg. Oncol. 22:2416-2413, 2015.

Reisinger, K. W., Bosmans, J. W., Uittenbogaart, M., Alsoumali, A., Poeze, M., Sosef, M. N., and Derikx, J. P. Loss of Skeletal Muscle Mass During Neoadjuvant Chemoradiotherapy Predicts Postoperative Mortality in Esophageal Cancer Surgery. Ann. Surg. Oncol. 22:4445-4452, 2015.

Fearon, K., Strasser, F., Anker, S. D., Bosaeus, I., Bruera, E., Fainsinger, R. L., Jatoi, A., Loprinzi, C., MacDonald, N., Mantovani, G., Davis, M., Muscaritoli, M., Ottery, F., Radbruch, L., Ravasco, P., Walsh, D., Wilcock, A., Kaasa, S., and Baracos, V. E. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 12:489-495, 2011.

Mitsiopoulos, N., Baumgartner, R. N., Heymsfield, S. B., Lyons, W., Gallagher, D., and Ross, R. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J. Appl. Physiol (1985. ). 85:115-122, 1998.

Miller, K. D., Jones, E., Yanovski, J. A., Shankar, R., Feuerstein, I., and Falloon, J. Visceral abdominal-fat accumulation associated with use of indinavir. Lancet. 351:871-875, 1998.

Shen, W., Punyanitya, M., Wang, Z., Gallagher, D., St-Onge, M. P., Albu, J., Heymsfield, S. B., and Heshka, S. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J. Appl. Physiol (1985. ). 97:2333-2338, 2004.

Eknoyan, G. Adolphe Quetelet (1796-1874)--the average man and indices of obesity. Nephrol. Dial. Transplant. 23:47-51, 2008.

Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., Fearon, K., Hutterer, E., Isenring, E., Kaasa, S., Krznaric, Z., Laird, B., Larsson, M., Laviano, A., Muhlebach, S., Muscaritoli, M., Oldervoll, L., Ravasco, P., Solheim, T., Strasser, F., de, v. d. S., and Preiser, J. C. ESPEN guidelines on nutrition in cancer patients. Clin. Nutr. 2016.

Martin, L., Birdsell, L., MacDonald, N., Reiman, T., Clandinin, M. T., McCargar, L. J., Murphy, R., Ghosh, S., Sawyer, M. B., and Baracos, V. E. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J. Clin. Oncol. 31:1539-1547, 2013.

Strasberg, S. M., Linehan, D. C., and Hawkins, W. G. The accordion severity grading system of surgical complications. Ann. Surg. 250:177-186, 2009.

Porembka, M. R., Hall, B. L., Hirbe, M., and Strasberg, S. M. Quantitative weighting of postoperative complications based on the accordion severity grading system: demonstration of potential impact using the american college of surgeons national surgical quality improvement program. J. Am. Coll. Surg. 210:286-298, 2010.

Windsor, J. A., and Hill, G. L. Weight loss with physiologic impairment. A basic indicator of surgical risk. Ann. Surg. 207:290-296, 1988.

Altman, D. G., and Royston, P. The cost of dichotomising continuous variables. BMJ. 332:1080, 2006.

Reis, J. P., Macera, C. A., Araneta, M. R., Lindsay, S. P., Marshall, S. J., and Wingard, D. L. Comparison of overall obesity and body fat distribution in predicting risk of mortality. Obesity. (Silver. Spring). 17:1232-1239, 2009.

Moon, H. G., Ju, Y. T., Jeong, C. Y., Jung, E. J., Lee, Y. J., Hong, S. C., Ha, W. S., Park, S. T., and Choi, S. K. Visceral obesity may affect oncologic outcome in patients with colorectal cancer. Ann. Surg. Oncol. 15:1918-1922, 2008.




DOI: http://dx.doi.org/10.17987/jcsm-cr.v2i1.13

Refbacks

  • There are currently no refbacks.